Central Repository for Digital Pathology

Akronym

BIGPICTURE

Bidragets beskrivning

BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to create the first European GDPR compliant platform, in which both quality-controlled Whole Slide Imaging (WSI) data and advanced Artificial intelligence (AI) algorithms will exist. The BIGPICTURE platform will be built on existing assets of ELIXIR EU data infrastructure, including the federated European Genome-phenome Archive (EGA) technology for managing the exchange of confidential information between contributors and users. The consortium will use Cytomine, an established open-source, cross-platform framework to develop unique tools for access to WSI, including annotations and visualisation of algorithm results, while we will develop new and generic models to facilitate AI development and mining of WSI data. By engaging and building consensus with all the relevant stakeholders, we will contribute to the development of a regulatory framework for digital slides and AI-based methods. Finally, BIGPICTURE envisions sustainability of its platform through a community- based model which relies on reciprocity, value creation and inclusiveness. To achieve our vision, we have brought together Europe’s leaders in the field of computational pathology who have access to national and European high-performance computing infrastructures as well as Europe’s fully digitalised pathology departments. Additionally, the consortium has currently access to approximately 4.5 million clinical WSI covering a wider range of indications through 17 partners and 23 third parties from the largest European and international pathology and trial groups. Our consortium is further strengthened by the presence of the European Society of Pathology, Digital Pathology Association, FDA and 9 SMEs as partners, while we are further supported by professional societies, and patient advocates.
Visa mer

Startår

2021

Slutår

2027

Beviljade finansiering

57 000 €
Third party
900 000 €
Participant
4 003 125 €
Participant
DIAGNEXIA UK LIMITED (UK)
131 250 €
Third party
LINKOPINGS UNIVERSITET (SE)
2 163 750 €
Participant
CYTOMINE CORPORATION SA (BE)
518 750 €
Participant
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (NL)
8 614 691.36 €
Coordinator
ROCHE DIAGNOSTICS INTERNATIONAL AG (CH)
Participant
DIGITAL PATHOLOGY ASSOCIATION INC (US)
12 000 €
Participant
PHIT BV (NL)
270 000 €
Participant
DECIPHEX LIMITED (IE)
2 318 750 €
Participant
OWKIN FRANCE (FR)
400 000 €
Participant
BAYER AKTIENGESELLSCHAFT (DE)
Participant
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (BE)
60 000 €
Participant
SECTRA AB (SE)
196 875 €
Participant
EUROPEAN SOCIETY OF PATHOLOGY (BE)
60 000 €
Participant
UCB BIOPHARMA SPRL (BE)
Participant
BIOBANKS AND BIOMOLECULAR RESOURCESRESEARCH INFRASTRUCTURE CONSORTIUM(BBMRI-ERIC) (AT)
209 000 €
Participant
TTOPSTART BV (NL)
160 000 €
Participant
THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST (UK)
950 150 €
Participant
TIME.LEX (BE)
240 000 €
Participant
OSTERGOTLANDS LAN (SE)
600 000 €
Participant
STICHTING LYGATURE (NL)
1 724 000 €
Participant
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (FR)
Participant
PFIZER LIMITED (UK)
Participant
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (FR)
Participant
BOEHRINGER INGELHEIM INTERNATIONALGMBH (DE)
Participant
JANSSEN PHARMACEUTICA NV (BE)
Participant
HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE (CH)
300 000 €
Participant
DIN DEUTSCHES INSTITUT FUER NORMUNG E.V. (DE)
98 412 €
Participant
DIN DEUTSCHES INSTITUT FUER NORMUNG EV (DE)
98 412.5 €
Participant
GBG FORSCHUNGS GMBH (DE)
72 000 €
Participant
F. HOFFMANN-LA ROCHE AG (CH)
Participant
NOVARTIS PHARMA AG (CH)
Participant
MEDIZINISCHE UNIVERSITAT GRAZ (AT)
232 000 €
Participant
PHILIPPS UNIVERSITAET MARBURG (DE)
600 000 €
Participant
SEMMELWEIS EGYETEM (HU)
72 000 €
Participant
UMEA UNIVERSITET (SE)
300 000 €
Third party
UNIVERSITAIR MEDISCH CENTRUM UTRECHT (NL)
600 000 €
Participant
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA (IT)
57 000 €
Third party
NOVO NORDISK A/S (DK)
Participant
UNIVERSITE DE LIEGE (BE)
1 625 375 €
Participant
THE UNIVERSITY OF WARWICK (UK)
399 982.5 €
Participant
TECHNISCHE UNIVERSITEIT EINDHOVEN (NL)
240 000 €
Participant
TECHNISCHE UNIVERSITAET MUENCHEN (DE)
312 000 €
Participant
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE)
240 006.25 €
Participant
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NL)
200 000 €
Participant
UPPSALA UNIVERSITET (SE)
2 325 000 €
Participant
MEDIZINISCHE UNIVERSITAET WIEN (AT)
619 429.89 €
Participant
KATHOLIEKE UNIVERSITEIT LEUVEN (BE)
57 000 €
Third party
INSTITUT PASTEUR (FR)
378 125 €
Participant

Beviljat belopp

32 319 825 €

Finansiär

Europeiska unionen

Typ av finansiering

Research and Innovation action

Ramprogram

Horizon 2020 Framework Programme

Utlysning

Programdel
Health (5290)
Innovative Medicines Initiative 2 (IMI2) (5312)
Tema
Central repository of digital pathology slides to support the development of artificial intelligence tools (IMI2-2019-18-01)
Utlysnings ID
H2020-JTI-IMI2-2019-18-two-stage

Övriga uppgifter

Finansieringsbeslutets nummer

945358

Identifierade teman

bioinformatics